Washington, Oct. 14 (SANA) Researchers at the Massachusetts Institute of Technology (MIT) have developed a technology that uses tiny nanoparticles to redirect immune cells toward disease-causing cells, potentially paving the way for new treatments for certain cancers and autoimmune diseases.
The institute said on Tuesday that the technology uses lipid nanoparticles to deliver genetic instructions to natural killer (NK) cells, a type of immune cell. The aim is to enable these cells to recognize and destroy targeted cells without having to extract immune cells from a patient, modify them in a laboratory and then return them to the body.
The researchers said the approach could simplify the production of immunotherapies and reduce their cost. The nanoparticles act as carriers for genetic instructions that help immune cells target specific cells, including cancer cells and immune cells that mistakenly attack the body’s own tissues.
The study found that the technology enabled the reprogramming of about 80% of the targeted immune cells. Experiments in research models of melanoma, a type of skin cancer, and T-cell lymphoma also showed reductions in tumor size, with tumors disappearing in some cases.
Potential applications in autoimmune diseases
The findings also indicated that the technology could help target T cells that attack the liver in models of autoimmune hepatitis. This reduced the number of these cells and limited liver damage in the models studied.
The technology’s significance lies in its potential to modify immune cell functions directly inside the body, avoiding complex laboratory procedures to alter the cells before returning them to the patient. This approach could simplify the development of certain immunotherapies and broaden their potential applications.
The researchers hope the findings will contribute to the development of new treatments for certain cancers and autoimmune diseases, including multiple sclerosis and rheumatoid arthritis.
However, further studies are needed to evaluate the technology’s safety and effectiveness in humans.
T.S /R.K